AKCEA THERAPEUTICS INC's ticker is AKCA and the CUSIP is 00972L107. A total of 1 filers reported holding AKCEA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $47,000 | +34.3% | 2,579 | 0.0% | 0.00% | – |
| Q2 2020 | $35,000 | +400.0% | 2,579 | +416.8% | 0.00% | – |
| Q1 2020 | $7,000 | -12.5% | 499 | 0.0% | 0.00% | – |
| Q4 2019 | $8,000 | -63.6% | 499 | -64.3% | 0.00% | – |
| Q3 2019 | $22,000 | -33.3% | 1,399 | 0.0% | 0.00% | – |
| Q2 2019 | $33,000 | -68.6% | 1,399 | -62.2% | 0.00% | -100.0% |
| Q1 2019 | $105,000 | -6.2% | 3,700 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $112,000 | -25.8% | 3,700 | -14.0% | 0.00% | 0.0% |
| Q3 2018 | $151,000 | +48.0% | 4,300 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $102,000 | -7.3% | 4,300 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $110,000 | -2.7% | 4,300 | -33.8% | 0.00% | 0.0% |
| Q4 2017 | $113,000 | -37.2% | 6,500 | 0.0% | 0.00% | -50.0% |
| Q3 2017 | $180,000 | – | 6,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 2,389,571 | $61,197,000 | 1.69% |
| Virtus ETF Advisers LLC | 39,351 | $1,008,000 | 0.88% |
| Eventide Asset Management | 175,000 | $4,482,000 | 0.21% |
| ALTRINSIC GLOBAL ADVISORS LLC | 187,800 | $4,810,000 | 0.19% |
| Bellevue Group AG | 48,799 | $1,250,000 | 0.12% |
| Perceptive Advisors | 97,144 | $2,488,000 | 0.07% |
| FMR LLC | 10,008,016 | $256,306,000 | 0.03% |
| WELLINGTON MANAGEMENT GROUP LLP | 3,384,101 | $86,667,000 | 0.02% |
| Virtu Financial LLC | 12,571 | $322,000 | 0.02% |
| Cubist Systematic Strategies, LLC | 7,843 | $201,000 | 0.01% |